Phase Angle as a Marker of Muscle Damage, Muscle Fatigue and Inflammation, After Eccentric Exercise
NCT ID: NCT05583500
Last Updated: 2022-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
28 participants
INTERVENTIONAL
2022-09-19
2023-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A sample of 28 sedentary subjects will be recruited, all participants will perform an eccentric exercise protocol.
Measurements will be done before performing the exercise protocol, immediately after finishing the protocol, 3h after the end of the exercise protocol, 24h after the end of the exercise protocol and 48h after the end of the exercise protocol.
The variables analyzed in all subjects will be phase angle, creatinkinase, jumping strength, VAS scale, white blood count cell, quadriceps muscle thickness, Borg scale and anxiety and depression questionnaires.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Eccentric Resistance Training With Blood Flow Restriction on Muscle Function
NCT04977804
Effects of Ischemic Preconditioning on Muscle Damage Induced by Excentric Exercise
NCT04420819
A Methodology Study to Assess Muscle Damage After Eccentric Exercise
NCT02014662
Study of Muscle Repair Following Exercise in Young and Elderly People
NCT02174692
Imaging Biomarkers of the Effects of a Mixed Exercise Program
NCT03834558
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single group: excentric exercise protocol
Excentric exercise protocol will be performed for all subjets, consisted of 10 sets of 20 repetitions of squats, jumping from a height of 50 cm
Experimental: Single group: excentric exercise protocol
Excentric exercise protocol will be performed for all subjets, consisted of 10 sets of 20 repetitions of squats, jumping from a height of 50 cm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental: Single group: excentric exercise protocol
Excentric exercise protocol will be performed for all subjets, consisted of 10 sets of 20 repetitions of squats, jumping from a height of 50 cm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sedentary subjects
Exclusion Criteria
* Subjects with musculoskeletal pathology
* Previous Surgeries in the last 6 months
* Subjects under pharmacological treatment
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Francisco de Vitoria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jorge Buffet García
Role: PRINCIPAL_INVESTIGATOR
Universidad Francisco de Vitoria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad Francisco de Vitoria
Pozuelo de Alarcón, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UFV-JB22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.